Asha S. Multani

13.4k total citations · 2 hit papers
126 papers, 8.2k citations indexed

About

Asha S. Multani is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Asha S. Multani has authored 126 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 42 papers in Oncology and 29 papers in Physiology. Recurrent topics in Asha S. Multani's work include Telomeres, Telomerase, and Senescence (28 papers), DNA Repair Mechanisms (26 papers) and Cancer-related Molecular Pathways (19 papers). Asha S. Multani is often cited by papers focused on Telomeres, Telomerase, and Senescence (28 papers), DNA Repair Mechanisms (26 papers) and Cancer-related Molecular Pathways (19 papers). Asha S. Multani collaborates with scholars based in United States, India and China. Asha S. Multani's co-authors include Sandy Chang, Sen Pathak, Sunil R. Hingorani, Ralph H. Hruban, Anil K. Rustgi, Lifu Wang, David A. Tuveson, Chelsea Combs, Thérèse B. Deramaudt and Wilfredo Cosme‐Blanco and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Asha S. Multani

123 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

2005 1.8k citations Asha S. Multani, Sandy Chang et al. profile →
Clonal evolution in breast cancer revealed by single nucleus genome sequencing

2014 711 citations Asha S. Multani et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Asha S. Multani United States	40	5.0k	3.3k	1.9k	1.4k	803	126	8.2k
Martha R. Stampfer United States	54	6.0k 1.2×	3.7k 1.2×	1.8k 0.9×	1.3k 1.0×	625 0.8×	132	9.4k
Roberta Maestro Italy	42	4.9k 1.0×	2.9k 0.9×	1.5k 0.8×	901 0.7×	914 1.1×	121	8.5k
Gerardo Ferbeyre Canada	43	5.5k 1.1×	2.0k 0.6×	1.3k 0.7×	1.8k 1.3×	1.1k 1.3×	122	7.8k
Samuel Benchimol Canada	46	5.7k 1.1×	4.6k 1.4×	1.4k 0.7×	1.3k 0.9×	671 0.8×	94	8.8k
Mila E. McCurrach United States	20	7.3k 1.5×	3.6k 1.1×	1.3k 0.7×	2.1k 1.5×	1.4k 1.7×	21	9.6k
Sam W. Lee United States	48	5.0k 1.0×	2.3k 0.7×	1.1k 0.6×	671 0.5×	1.2k 1.5×	93	7.1k
Atsushi Hirao Japan	44	7.2k 1.4×	3.2k 1.0×	1.9k 1.0×	1.0k 0.8×	2.4k 3.0×	132	12.4k
Laura D. Attardi United States	48	9.4k 1.9×	4.3k 1.3×	3.9k 2.1×	947 0.7×	736 0.9×	104	12.4k
Alexei Protopopov United States	41	5.6k 1.1×	1.4k 0.4×	2.1k 1.1×	972 0.7×	744 0.9×	88	8.0k
Vjekoslav Dulić France	28	5.5k 1.1×	4.2k 1.3×	886 0.5×	1.1k 0.8×	498 0.6×	41	7.7k

Countries citing papers authored by Asha S. Multani

Since Specialization

Citations

This map shows the geographic impact of Asha S. Multani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asha S. Multani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asha S. Multani more than expected).

Fields of papers citing papers by Asha S. Multani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asha S. Multani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asha S. Multani. The network helps show where Asha S. Multani may publish in the future.

Co-authorship network of co-authors of Asha S. Multani

This figure shows the co-authorship network connecting the top 25 collaborators of Asha S. Multani. A scholar is included among the top collaborators of Asha S. Multani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asha S. Multani. Asha S. Multani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Jangsoon, Kumiko Kida, Jiwon Koh, et al.. (2024). The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 236–236. 9 indexed citations

Li, Mi, Amriti R. Lulla, Spyros Tsavachidis, et al.. (2024). Low–Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer. Cancer Research. 84(22). 3864–3880. 4 indexed citations

Ghayee, Hans K., Yiling Xu, Heather Hatch, et al.. (2022). Development of Human Adrenocortical Adenoma (HAA1) Cell Line from Zona Reticularis. International Journal of Molecular Sciences. 24(1). 584–584. 1 indexed citations

Wu, Shaofang, Feng Gao, Siyuan Zheng, et al.. (2019). EGFR Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma. Clinical Cancer Research. 26(6). 1395–1407. 34 indexed citations

Verstovšek, Srđan, Taghi Manshouri, Darrell Pilling, et al.. (2016). Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis. The Journal of Experimental Medicine. 213(9). 1723–1740. 115 indexed citations

Malouf, Gabriel G., Federico A. Monzon, Jérôme Couturier, et al.. (2013). Genomic Heterogeneity of Translocation Renal Cell Carcinoma. Clinical Cancer Research. 19(17). 4673–4684. 61 indexed citations

Wagner, Klaus W., Hunain Alam, Shilpa S. Dhar, et al.. (2013). KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling. Journal of Clinical Investigation. 123(12). 5231–5246. 149 indexed citations

Chen, Xin, Bigang Liu, Qiuhui Li, et al.. (2013). Dissociated Primary Human Prostate Cancer Cells Coinjected with the Immortalized Hs5 Bone Marrow Stromal Cells Generate Undifferentiated Tumors in NOD/SCID-γ Mice. PLoS ONE. 8(2). e56903–e56903. 10 indexed citations

Akbay, Esra A., Christopher G. Peña, Yuji Nakada, et al.. (2012). Cooperation between p53 and the telomere-protecting shelterin component Pot1a in endometrial carcinogenesis. Oncogene. 32(17). 2211–2219. 24 indexed citations

10.

Dalal, Poonam, et al.. (2012). THE STUDY OF RESPIRATORY AND ABDOMINAL MANIFESTATIONS IN ALUMINIUM PHOSPHIDE POISONING. Journal of Punjab Academy of Forensic Medicine & Toxicology. 12(1). 25–28. 1 indexed citations

11.

Dalal, Poonam, et al.. (2011). Clinico-medicolegal study of aluminium phosphide poisoning. Medico-Legal Update. 11(1). 1 indexed citations

12.

Yang, Gong, Bin Chang, Fan Yang, et al.. (2010). Aurora Kinase A Promotes Ovarian Tumorigenesis through Dysregulation of the Cell Cycle and Suppression of BRCA2. Clinical Cancer Research. 16(12). 3171–3181. 111 indexed citations

13.

Sung, Shian‐Ying, Chia‐Ling Hsieh, Andrew M. K. Law, et al.. (2008). Coevolution of Prostate Cancer and Bone Stroma in Three-Dimensional Coculture: Implications for Cancer Growth and Metastasis. Cancer Research. 68(23). 9996–10003. 124 indexed citations

14.

Li, Zhigang, Nora M. Navone, H. J. Yang, et al.. (2008). Androgen receptor-negative human prostate cancer cells induce osteogenesis through FGF9-mediated mechanisms. Cancer Research. 68. 1612–1612. 10 indexed citations

15.

Cook, Kendra R., Balraj Singh, Laura Vincent, et al.. (2008). 41. Cyclooxygenase-2 Induces Genomic Instability, BCL2 Expression, Doxorubicin Resistance, and Altered Cancer Initiating Cell Phenotype in MCF7 Breast Cancer Cells. Journal of Surgical Research. 144(2). 193–194. 3 indexed citations

16.

Akli, Saïd, Carolyn S. Van Pelt, Tuyen Bui, et al.. (2007). Overexpression of the Low Molecular Weight Cyclin E in Transgenic Mice Induces Metastatic Mammary Carcinomas through the Disruption of the ARF-p53 Pathway. Cancer Research. 67(15). 7212–7222. 61 indexed citations

17.

Akli, Saïd, Asha S. Multani, Hannah F. Wingate, et al.. (2004). Tumor-Specific Low Molecular Weight Forms of Cyclin E Induce Genomic Instability and Resistance to p21, p27, and Antiestrogens in Breast Cancer. Cancer Research. 64(9). 3198–3208. 117 indexed citations

18.

Multani, Asha S., et al.. (2002). Telomere Dynamics, Aging, and Cancer: Study of Human Syndromes Characteristic of Premature Aging. 5(3). 271–281. 1 indexed citations

19.

Multani, Asha S., Mustafa Özen, Joya Chandra, et al.. (2000). Caspase-Dependent Apoptosis Induced by Telomere Cleavage and TRF2 Loss. Neoplasia. 2(4). 339–345. 45 indexed citations

20.

Pathak, Sen, Margit A. Nemeth, & Asha S. Multani. (1999). Author reply. Cancer. 86(5). 899–900. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact